DK1927351T3 - Anvendelse af agomelatin til at opnå lægemidler rettet mod at behandle periventrikulær leukomalaci - Google Patents

Anvendelse af agomelatin til at opnå lægemidler rettet mod at behandle periventrikulær leukomalaci

Info

Publication number
DK1927351T3
DK1927351T3 DK07291392.4T DK07291392T DK1927351T3 DK 1927351 T3 DK1927351 T3 DK 1927351T3 DK 07291392 T DK07291392 T DK 07291392T DK 1927351 T3 DK1927351 T3 DK 1927351T3
Authority
DK
Denmark
Prior art keywords
agomelatine
periventricular leukomalacia
drugs aimed
obtain drugs
treating
Prior art date
Application number
DK07291392.4T
Other languages
English (en)
Inventor
Michael Spedding
Elisabeth Mocaer
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38229589&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1927351(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK1927351T3 publication Critical patent/DK1927351T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK07291392.4T 2006-11-24 2007-11-23 Anvendelse af agomelatin til at opnå lægemidler rettet mod at behandle periventrikulær leukomalaci DK1927351T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0610294A FR2908994B1 (fr) 2006-11-24 2006-11-24 Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement de la leucomalacie periventriculaire

Publications (1)

Publication Number Publication Date
DK1927351T3 true DK1927351T3 (da) 2011-01-10

Family

ID=38229589

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07291392.4T DK1927351T3 (da) 2006-11-24 2007-11-23 Anvendelse af agomelatin til at opnå lægemidler rettet mod at behandle periventrikulær leukomalaci

Country Status (37)

Country Link
US (1) US20080125493A1 (da)
EP (1) EP1927351B1 (da)
JP (1) JP4870062B2 (da)
KR (1) KR100976000B1 (da)
CN (1) CN101185644B (da)
AR (1) AR063895A1 (da)
AT (1) ATE483458T1 (da)
AU (1) AU2007234600B2 (da)
BR (1) BRPI0704179A (da)
CA (1) CA2610637C (da)
CL (1) CL2007003395A1 (da)
CY (1) CY1110875T1 (da)
DE (1) DE602007009627D1 (da)
DK (1) DK1927351T3 (da)
EA (1) EA014067B1 (da)
ES (1) ES2353128T3 (da)
FR (1) FR2908994B1 (da)
GE (1) GEP20094747B (da)
HR (1) HRP20100680T1 (da)
JO (1) JO2631B1 (da)
MA (1) MA29522B1 (da)
ME (1) ME01866B (da)
MX (1) MX2007014004A (da)
MY (1) MY145925A (da)
NO (1) NO338598B1 (da)
NZ (1) NZ563683A (da)
PE (1) PE20081158A1 (da)
PL (1) PL1927351T3 (da)
PT (1) PT1927351E (da)
RS (1) RS51494B (da)
SG (1) SG143202A1 (da)
SI (1) SI1927351T1 (da)
TW (1) TW200829236A (da)
UA (1) UA94043C2 (da)
UY (1) UY30703A1 (da)
WO (1) WO2008071869A2 (da)
ZA (1) ZA200710102B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2810647A1 (en) 2013-06-06 2014-12-10 Zentiva, a.s. Pharmaceutical formulations comprising agomelatine in the form of agomelatine co-crystal with an organic acid
ES2645223T3 (es) 2013-06-06 2017-12-04 Zentiva, K.S. Formulaciones de agomelatina que comprenden agomelatina en forma de co-cristales

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
WO2003011271A2 (en) * 2001-08-03 2003-02-13 Children's Medical Center Corporation Methods and compositions for modulating brain damage
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine
US7358395B2 (en) * 2005-08-03 2008-04-15 Les Laboratories Servier Crystalline form V of agomelatine, a process for its preparation and pharmaceutical compositions containing it

Also Published As

Publication number Publication date
WO2008071869A2 (fr) 2008-06-19
AR063895A1 (es) 2009-02-25
DE602007009627D1 (de) 2010-11-18
BRPI0704179A (pt) 2008-07-08
GEP20094747B (en) 2009-07-27
UY30703A1 (es) 2008-01-02
NO20076002L (no) 2008-05-26
NZ563683A (en) 2009-04-30
EP1927351A1 (fr) 2008-06-04
MX2007014004A (es) 2009-02-16
HRP20100680T1 (hr) 2011-01-31
FR2908994A1 (fr) 2008-05-30
ATE483458T1 (de) 2010-10-15
JO2631B1 (en) 2012-06-17
CA2610637A1 (fr) 2008-05-24
AU2007234600A1 (en) 2008-06-12
KR20080047298A (ko) 2008-05-28
ME01866B (me) 2011-04-30
PT1927351E (pt) 2010-10-27
KR100976000B1 (ko) 2010-08-17
PE20081158A1 (es) 2008-10-04
WO2008071869A3 (fr) 2008-08-14
MA29522B1 (fr) 2008-06-02
NO338598B1 (no) 2016-09-12
MY145925A (en) 2012-05-15
SI1927351T1 (sl) 2010-12-31
RS51494B (sr) 2011-04-30
UA94043C2 (ru) 2011-04-11
FR2908994B1 (fr) 2009-04-03
SG143202A1 (en) 2008-06-27
CN101185644B (zh) 2011-08-10
HK1118216A1 (en) 2009-02-06
AU2007234600A8 (en) 2010-12-02
JP4870062B2 (ja) 2012-02-08
CA2610637C (fr) 2011-04-19
TW200829236A (en) 2008-07-16
ZA200710102B (en) 2008-11-26
EA200702317A1 (ru) 2008-06-30
AU2007234600B2 (en) 2012-05-17
ES2353128T3 (es) 2011-02-25
CY1110875T1 (el) 2015-06-10
US20080125493A1 (en) 2008-05-29
EA014067B1 (ru) 2010-08-30
PL1927351T3 (pl) 2011-01-31
EP1927351B1 (fr) 2010-10-06
JP2008133279A (ja) 2008-06-12
CL2007003395A1 (es) 2008-09-12
CN101185644A (zh) 2008-05-28

Similar Documents

Publication Publication Date Title
DK1842535T3 (da) Anvendelse af agomelatin til at opnå medicin rettet mod at behandle generelle angstforstyrrelser
BRPI0811265A2 (pt) Tratamento de sinucleinopatias
DE602007000323D1 (de) Abgabe von therapeutischen Vorrichtungen
CY2015046I2 (el) Τροποποιητες φαρμακοκινητικων ιδιοτητων θεραπευτικων ειδων
DK2222272T3 (da) Behandling af luftvejssygdom
BRPI0915476A2 (pt) dispositivo para tratar problemas respiratórios
BRPI0908428A2 (pt) uso de ranozalina para tratar a dor.
EP2229353A4 (en) HYDROCYANATION OF PENTENNITRILES
BRPI0807487A2 (pt) Uso de antagonistas de il-23 para o tratamento de infecção
DK2117525T3 (da) Anvendelse af 1-phenyl-3-dimethylamino-propanforbindelser til behandling af neuropatismerte
EP2109720A4 (en) SELF-STABLE THRUST-SAFETY CLAMP
EP3381471C0 (en) PAIN TREATMENT
DK1942938T3 (da) Anvendelse af oligouronater til behandling af slim-hyperviskositet
BRPI0722183A2 (pt) Composições farmacêuticas para tratar depressão e ansiedade
BRPI0715728A2 (pt) tratamento de distérbio cartilaginosos
LTC2066352I2 (lt) Išsėtinės sklerozės (MS) gydymas kampatu-1H
DK2175849T3 (da) Behandling af melanomer
PT2330892T (pt) Métodos de tratamento usando fármacos eliminadores de amónia
EP2408908A4 (en) ENDOGLUCANASE VARIATIONS AND CORRESPONDING POLYNUCLEOTIDES
DK1929999T3 (da) Anvendelse af agomelatin til at opnå medicin rettet mod at behandle Smith-Magenis-syndrom
DK2173366T3 (da) Anvendelse af bigift til behandling af parkinson's sygdom
FI20065834A0 (fi) Iskulaite
DK2344253T3 (da) Anvendelse af histon-deacetylase-inhibitorer til pleje af philadelphia-negative myeloproliferative syndromer
DK1927351T3 (da) Anvendelse af agomelatin til at opnå lægemidler rettet mod at behandle periventrikulær leukomalaci
BRPI0722185A2 (pt) Composições farmacêuticas para tratar ansiedade